Effects of Myofascial Release and TENS Over Pain, Hand Prehensile Strength and Functionality of Superior Extremity in Women With Lateral Epicondylalgia
NCT ID: NCT04023279
Last Updated: 2019-07-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
32 participants
INTERVENTIONAL
2018-09-24
2018-12-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of Radial Nerve Mobilization for Chronic Epicondylalgia
NCT07146620
Fascial Manipulation on the Treatment of Carpal Tunnel Syndrome
NCT02495298
Dry Needling, Manipulation and Stretching vs. Manual Therapy, Exercise and Ultrasound for Lateral Epicondylalgia
NCT03167710
Myofascial Release on Electrophysiological Measures of Pregnant Women With CTS
NCT03802448
Manual Therapy, Exercise and US Vs. Manual Therapy, Exercise and US for Medial Epicondylalgia
NCT04609735
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Contrary to the hypothesis, the application of myofascial release therapy added to the application of TENS proved to generate a significant change only in the prehensile hand force with respect to the group that received only TENS.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
The assessor in charge of evaluating the participants was blind to the treatment assignment, where he proceeded to take the measurements with a prior instruction of the procedures.
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
TENS
Conventional TENS of 100 Hz and 100 usec for 20 minutes
TENS
100 Hz and 100 usec for 20 minutes
Myofascial Therapy
Conventional TENS of 100 Hz and 100 usec for 20 minutes plus myofascial release therapy in the brachial biceps; Seven to fifteen transverse sliding repetitions and three repetitions of longitudinal sliding
TENS
100 Hz and 100 usec for 20 minutes
Myofascial therapy
Seven to fifteen transverse sliding repetitions and three repetitions of longitudinal sliding of myofascial release therapy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
TENS
100 Hz and 100 usec for 20 minutes
Myofascial therapy
Seven to fifteen transverse sliding repetitions and three repetitions of longitudinal sliding of myofascial release therapy
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Belong to the administrative staff of the university in question
* Have a symptomatic diagnosis of chronic lateral epicondylitis (\> 6 weeks)
Exclusion Criteria
* Have done moderate or intense aerobic or anaerobic sport activities of any kind 72 hours before the registrations
* Have an orthopedic, rheumatologic, neuropsychiatric or associated comorbidities diagnosed.
* Have suffered a fracture or trauma involving the upper extremity 4 months before the intervention.
* Be in medical, pharmacological or kinesthetic treatment during the intervention or 2 weeks before this.
30 Years
50 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fernanda Merino Alvarez
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Fernanda Merino Alvarez
Sponsor and Principal Investigator Fernanda Merino Alvarez
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jorge Fuentes, PhD
Role: STUDY_DIRECTOR
Universidad Andres Bello
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universidad Andres Bello
Talcahuano, Concepción, Chile
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UniversidadNAB
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.